Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acs.nanolett.0c02278 http://scihub22266oqcxt.onion/10.1021/acs.nanolett.0c02278 32551679!ä!32551679       Nano+Lett 2020 ; 20 (7): 5570-5574 Nephropedia Template TP {{tp|p=32551679|t=2020. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity |pdf=|usr=}}{{32551679}} gab.com Text Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity JO: Nano Lett http://www.kidney.de/pget.php?&tw=1&pmid=32551679 #FOAvip We report cellular nanosponges as an effective medical countermeasure to the SARS-CoV-2 virus. Two types of cellular nanosponges are made of the plasma membranes derived from human lung epithelial type II cells or human macrophages. These nanosponges display the same protein receptors, both identified and unidentified, required by SARS-CoV-2 for cellular entry. It is shown that, following incubation with the nanosponges, SARS-CoV-2 is neutralized and unable to infect cells. Crucially, the nanosponge platform is agnostic to viral mutations and potentially viral species, as well. As long as the target of the virus remains the identified host cell, the nanosponges will be able to neutralize the virus. Twit Text FOAVip Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity ????Nano Lett http://www.kidney.de/pget.php?&tw=1&pmid=32551679 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32551679 #FOAvip English Wikipedia <ref>{{Cite pmid|32551679}}</ref> Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity #MMPMID32551679 Zhang Q; Honko A; Zhou J; Gong H; Downs SN; Vasquez JH; Fang RH; Gao W; Griffiths A; Zhang L Nano Lett 2020[Jul]; 20 (7): 5570-5574 PMID32551679show ga We report cellular nanosponges as an effective medical countermeasure to the SARS-CoV-2 virus. Two types of cellular nanosponges are made of the plasma membranes derived from human lung epithelial type II cells or human macrophages. These nanosponges display the same protein receptors, both identified and unidentified, required by SARS-CoV-2 for cellular entry. It is shown that, following incubation with the nanosponges, SARS-CoV-2 is neutralized and unable to infect cells. Crucially, the nanosponge platform is agnostic to viral mutations and potentially viral species, as well. As long as the target of the virus remains the identified host cell, the nanosponges will be able to neutralize the virus. |*Betacoronavirus/pathogenicity/physiology[MESH] |*Nanostructures/ultrastructure[MESH] |COVID-19[MESH] |Cell Membrane/virology[MESH] |Coronavirus Infections/*prevention & control/virology[MESH] |Epithelial Cells/virology[MESH] |Host Microbial Interactions[MESH] |Humans[MESH] |Lung/cytology/virology[MESH] |Macrophages/virology[MESH] |Nanotechnology[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control/virology[MESH] |Receptors, Virus/physiology[MESH] |SARS-CoV-2[MESH]Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity (epmc).pdf DeepDyve Pubget Overpricing